Nitec Pharma AG

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

2 documents for Nitec Pharma AG

- Nitec Pharma Licenses Tarenflurbil for Chronic Inflammation and Pain.
BASEL, Switzerland & FRANKFURT, Germany -- Nitec Pharma AG, an emerging specialty pharma company, today announces the signing of an agreement with PAZ...
- Business Wire
- November 05, 2007
- Lodotra(TM) Shows a Sustained Reduction of Morning Stiffness in Patients with Rheumatoid Arthritis Treated with Lodotra(TM) for 12 Months.
Nitec Presents Results of the Completed CAPRA-1 study (C...REINACH & BASEL, Switzerland -- Nitec Pharma AG today announced the results of the CAPRA-1 stud...
- Business Wire
- November 08, 2007